Miscellaneous ocular agents:
Indications for YUTIQ:
Chronic non-infectious posterior segment uveitis.
Give by intravitreal inj. See full labeling for administration.
Ocular or periocular infections.
Monitor for increased IOP and endophthalmitis; may include check for perfusion of the optic nerve head immediately, tonometry within 30 mins, and biomicroscopy between 2–7 days post injection. Risk of secondary ocular infections (eg, bacterial, fungal, viral). History of ocular herpes simplex: not recommended. Risk of implant migration if absent or torn posterior capsule of the lens. Pregnancy. Nursing mothers.
Cataract development, increased IOP; injection-related effects (eg, endophthalmitis, eye inflammation, choroidal/retinal detachments), glaucoma, others.
Generic Drug Availability:
Single-use applicator—1 (w. needle)